Approval · Notice of Compliance 21058 · 2018
SOLIQUA: Notice of Compliance 21058
Issued July 6, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21058
- Date
- July 6, 2018
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SOLIQUA | 02478293 | Marketed |
Medicinal ingredients
- INSULIN GLARGINE 100 UNIT per ML
- LIXISENATIDE 33 MCG per ML